Ann: Change in substantial holding, page-148

Statement of the Bleeding Obvious Ahead!

GG himself [family] highly likely do not have the organisational/managerial structures in place to "run" MSB...of course they don't!

Overall, I suspect he rates the Prof and his team around a 7.5-8 out of 10.....he's likely happy to remain a significant "observant" shareholder....he MAY want an enhanced Board rep position.....I suspect he'll want a few meaningful changes, but overall happy for the Prof and team to keep on keeping on.....beyond the short/medium term....who knows about anything! THE Absolute KEY thing for MSB is the OBVIOUS....get its first FDA Approval....DONE! Everything revolves around that.....the dollars are - potentially - off all the charts for this company, IF it can get its cell based technology over the line and the sooner it can do that, the better - without cutting corners and getting another CRL!